Rights and permissions
About this article
Cite this article
IVIG effective option for refractory polymyositis. Inpharma Wkly. 1334, 15 (2002). https://doi.org/10.2165/00128413-200213340-00032
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213340-00032